BREAKING NEWS: HGS rejects GSK $2.60 billion takeover bid

Article Date: 19/04/2012 10:03
BREAKING NEWS: HGS rejects GSK $2.60 billion takeover bid

Vacancy Search

Quick job search

Advanced Search

Latest News

Bigger is better for Sorin-Cyberonics combination

The starting gun on the medtech M&A derby of 2015 fired yesterday with the tie-up of the US-based Cyberonics and Italian company Sorin, a combination that should offer bargain-hunting...

Upcoming events: pacritinib in myelofibrosis and an adcom for Kythera

Welcome to your weekly digest of approaching regulatory and clinical readouts. By the end of the first quarter CTI Biopharma is expected to report topline phase III results of pacritinib in...

Boehringer puts BACE inhibitor trial on hold

Boehringer puts BACE inhibitor trial on hold

EMA will review Amgen/Onyx' myeloma drug

EMA will review Amgen/Onyx' myeloma drug

New indication for Bayer/Regeneron's Eylea in EU

New indication for Bayer/Regeneron's Eylea in EU

Newron Parkinson's drug Xadago gets Europe okay

Newron Parkinson's drug Xadago gets Europe okay

NICE backs biologics for ulcerative colitis

NICE backs biologics for ulcerative colitis

Bayer books record sales for 2014

Bayer books record sales for 2014

FDA gives green light to Sanofi Lantus follow-up Toujeo

FDA gives green light to Sanofi Lantus follow-up Toujeo

Pharmacyclics up for sale: Bloomberg

Pharmacyclics up for sale: Bloomberg
more news